Probiotics: a new way to fight bacterial pulmonary infections?

Y Alexandre1, G Le Blay2, S Boisramé-Gastrin1

  • 1Laboratoire universitaire de biodiversité et d'écologie microbienne, EA3882, faculté de médecine, université européenne de Bretagne, CHRU de la Cavale Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France.

Insights

Probiotics show promise as an alternative to antibiotics for treating respiratory infections, offering health benefits to the host. Further research is needed to optimize their use in clinical settings.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotics revolutionized infectious disease treatment but rising resistance necessitates alternatives.
  • Probiotics, live microorganisms conferring host health benefits, are a potential therapeutic avenue.
  • Respiratory tract infections (RTIs) represent a significant area for probiotic application.

Purpose of the Study:

  • To explore the rational application of probiotics in managing respiratory tract infections.
  • To review clinical study outcomes on probiotic use for various RTIs.
  • To assess the therapeutic potential and challenges of probiotics in respiratory health.

Main Methods:

  • Literature review of clinical studies on probiotics for RTIs.
  • Analysis of probiotic efficacy in conditions like pneumonia and cystic fibrosis.
  • Synthesis of evidence regarding probiotic mechanisms and administration.

Main Results:

  • Clinical study results on probiotics for RTIs are varied and sometimes contradictory.
  • Probiotics demonstrate potential therapeutic benefits in managing certain respiratory conditions.
  • Understanding specific probiotic strain mechanisms is crucial for effective application.

Conclusions:

  • Probiotics represent a promising therapeutic alternative for respiratory infections.
  • Further research is essential to elucidate mechanisms and optimize probiotic strategies.
  • Tailored approaches considering strain, dose, and administration are key for future clinical success.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...